Recent Updates
Recently added Catalysts
TECH Neutral Sentiment Score: 60/100

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a....

Key Takeaway: Bio-Techne Corporation has announced that it will host a conference call and webcast on August 6, 2025, at 8:00 a.m. CDT to discuss its fourth quarter and fiscal 2025 financial results. The call will be accessible via dial-in and a webcast link, allowing for broad participation. A recorded version will also be available after the live event for those unable to attend.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bio-Techne is set to provide insights into its financial performance.
  • The company has shown strong financial growth with $1.2 billion in net sales.

Full Press Release Details

MINNEAPOLIS , July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025 , at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results.
Access to the discussion may be obtained as follows:
Time: 8:00 a.m. CDT
Date: August 6, 2025
Dial-in: 1-800-274-8461 or 1-203-518-9814 (for international callers)
Conference ID: TECHQ4
Webcast: https://investors.bio-techne.com/ir-calendar
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11159590.
The replay will be available from 11:00 a.m. CDT on Wednesday , August 6, 2025, until 11:00 p.m. CDT on Saturday, September 6, 2025 .
About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH ) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook , LinkedIn , Twitter or YouTube .
Contact: David Clair , Vice President, Investor Relations & Corporate Development [email protected] 612-656-4416
SOURCE Bio-Techne Corporation

21 %

Frequently Asked Questions

When will Bio-Techne announce its Q4 and fiscal 2025 results?

Bio-Techne will announce its results on August 6, 2025, at 8:00 a.m. CDT.

How can I access Bio-Techne's conference call?

You can access it by dialing 1-800-274-8461 or via the webcast link provided.

Is there a way to listen to the conference call later?

Yes, a replay will be available from August 6 until September 6, 2025.

What is Bio-Techne Corporation known for?

Bio-Techne provides innovative tools and bioactive reagents for research and diagnostics.

How many employees does Bio-Techne have?

Bio-Techne has approximately 3,100 employees worldwide.

Last updated: Jul 17, 2025